PDS Biotechnology Corporation PDSB
1.45 USD +0.04 (+2.92%)
Nov 4, 2026, 9:46 AM EST
1.42 Day range 1.48
0.195 52-week range 1.79
- YTD
- +88.47%
- 1 year
- +63.24%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 11.50 +692.4% upside
Now 1.45
- Target (low)
- 4.50
- Target (mean)
- 11.50
- Target (high)
- 21.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.29667 | -0.34 – -0.25 | -0.35 | +15.2% | 0 | 0.0% | 6 |
| Next quarter | -0.33333 | -0.37 – -0.29 | -0.30 | -11.1% | 0 | 0.0% | 3 |
| Current year | -1.13 | -1.19 – -1.10 | -1.39 | +18.7% | 0 | 0.0% | 6 |
| Next year | -1.42 | -1.95 – -1.15 | -1.13 | -25.8% | 0 | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 25, 2024 | B. Riley Securities | Maintained | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 20, 2024 | Alliance Global Partners | Maintained | Buy | Buy |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2024 | B. Riley Securities | Maintained | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 9, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Mar 28, 2024 | B. Riley Securities | Reiterated | Buy | Buy |
| Mar 27, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 15, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 27, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 6, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 26, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 26, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Apr 24, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 30, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 29, 2023 | B. Riley Securities | Reiterated | — | Buy |
| Mar 28, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 28, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Jan 3, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
